CSIRO LEADS NEW ERA FOR BIOMEDICAL MANUFACTURING IN AUSTRALIA: Long-term benefits for industry and community as expanded manufacturing capability continues to support innovation, strengthen biosecurity, and help the Indo-Pacific region.

The article focuses on Professor Susie Nilsson's pivotal role in advancing biomedical manufacturing at CSIRO, particularly through rapid vaccine development during the COVID-19 pandemic and the establishment of new manufacturing facilities. It highlights CSIRO's efforts to address gaps in Australia's biotech ecosystem, such as the National Vaccine and Therapeutics Lab, and its plans to expand capabilities in producing biologics, therapeutics, and regulated medical devices.